(0.09%) 5 251.00 points
(0.02%) 39 650 points
(0.17%) 18 286 points
(0.09%) $78.33
(1.29%) $2.28
(-0.78%) $2 356.40
(-0.41%) $28.39
(0.03%) $1 007.50
(-0.05%) $0.928
(0.31%) $10.87
(0.01%) $0.798
(-0.95%) $91.79
Quarter results today
(bmo 2024-05-13)
Expected move: +/- 11.80%
@ $5.26
Issued: 14 Feb 2024 @ 12:24
Return: -33.27%
Previous signal: Feb 12 - 12:29
Previous signal:
Return: -3.66 %
Live Chart Being Loaded With Signals
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer...
Stats | |
---|---|
Today's Volume | 1.02M |
Average Volume | 954 372 |
Market Cap | 128.74M |
EPS | $0 ( 2024-03-27 ) |
Next earnings date | ( $-0.370 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.53 |
ATR14 | $0.00900 (0.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Toutain Stephan | Buy | 200 000 | Employee Stock Option (Right to Buy) |
2024-05-01 | Toutain Stephan | Buy | 0 | |
2024-01-22 | Shepard Kirk V. | Buy | 200 000 | Employee Stock Option (Right to Buy) |
2024-01-22 | Shepard Kirk V. | Buy | 0 | |
2023-12-04 | Boesgaard Lars | Buy | 200 000 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
77.35 |
Last 92 transactions |
Buy: 4 991 106 | Sell: 920 084 |
Volume Correlation
PDS Biotechnology Corp Correlation
10 Most Positive Correlations | |
---|---|
BRZE | 0.889 |
TBBK | 0.884 |
LUNA | 0.878 |
EA | 0.876 |
AMRS | 0.875 |
AZ | 0.873 |
DMRC | 0.868 |
PRFT | 0.868 |
LIAN | 0.863 |
BCEL | 0.858 |
10 Most Negative Correlations | |
---|---|
SIEB | -0.91 |
CTIC | -0.9 |
RILYM | -0.898 |
PPTA | -0.879 |
CURI | -0.879 |
LWAY | -0.874 |
SCTL | -0.873 |
CDXC | -0.873 |
TIGO | -0.872 |
SIGA | -0.872 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PDS Biotechnology Corp Correlation - Currency/Commodity
PDS Biotechnology Corp Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-57 326.00 (0.00 %) |
EPS: | $-1.390 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-57 326.00 (0.00 %) |
EPS: | $-1.390 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-49 078.00 (0.00 %) |
EPS: | $-1.430 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-0.660 |
Financial Reports:
No articles found.
PDS Biotechnology Corp
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators